Flu shot in newly diagnosed type 1 diabetes patients
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial checks whether giving a flu vaccine to people who were just diagnosed with type 1 diabetes affects their health and immune response. It may help doctors understand if flu vaccination is safe and useful soon after diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are hospitalized with newly diagnosed type 1 diabetes
- You (and a parent/legal guardian, if needed) can give written consent
- You have not already received a flu vaccine during this current flu season
- You are not having a fever or an active infection that is ongoing or suspected right now
- You can receive this specific flu vaccine safely (no severe past reaction to flu shots or eggs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a vaccine given to very young babies (3–4 months old) can prevent type 1 diabetes. It is designed for babies who have a high genetic risk and a family history of the disease.
This trial tests if repeated infusions of rituximab (a drug that calms the immune system) can help preserve insulin production in adolescents newly diagnosed with type 1 diabetes. It is for teens in Russia who started diabetes treatment within the last 4 months.
This trial tests a new way to give a medicine called anti-thymocyte globulin (ATG) with or without verapamil, a blood pressure drug. It aims to slow down the loss of insulin-making cells in people newly diagnosed with type 1 diabetes.
This study tests whether combining a shingles vaccine (Shingrix) with a diabetes medicine (semaglutide) can help preserve the body's ability to make insulin in people recently diagnosed with type 1 diabetes. It may slow the progression of the disease and reduce insulin needs.
This study tests a low dose of a drug that calms the immune system, followed by either another immune drug or a blood pressure medicine, to see if they can help preserve the body's ability to make insulin in people recently diagnosed with type 1 diabetes. It may help keep your own insulin production going longer.
This study tests whether teplizumab can help keep the body making insulin in people recently diagnosed with type 1 diabetes. It is for children and young adults aged 1 to 25, and compares the drug against a placebo.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.